Biotech Investment Analyst, Drug Asset & Company Assessment
About this role
Mercor is partnering with a biotech and pharma research team on expert human-evaluation work, creating and critiquing rubrics that analyze commercial drugs and drug-development programs. We're seeking a biotech investment analyst (specialist-fund background) for a paid pilot, with the potential to continue as the work scales.
Responsibilities
- Create and critique rubrics that analyze commercial drugs and drug-development programs
- Provide overall company and asset assessment, mechanism, clinical data, competitive position, and value drivers
- Judge the quality of an investment-style thesis and flag weak, overconfident, or missing assumptions
- Apply your assessment across the pilot's set of companies (~5 to 10)
Requirements
- US-based biotech / healthcare investment analyst with a specialist-fund background
- Familiarity with biotech/pharma development programs
- Able to assess a drug asset and the company behind it end-to-end
- 5+ years evaluating biotech/pharma companies or assets
Engagement Details
- Duration: Approximately 10 to 20 hours over a 1 to 2 week pilot
- Remote, US-based
Why Participate
- Help improve expert AI evaluation of drugs and drug-development programs
- Recurring engagement for strong contributors
Details
- Pay: $120 to $200/hr
- Company: Mercor
- Location: Remote
- Eligible locations: US-based or deep US-market experience
- Platform: Mercor
Frequently asked questions
How much does the Biotech Investment Analyst, Drug Asset & Company Assessment role pay?
Mercor lists this Biotech Investment Analyst, Drug Asset & Company Assessment position at $120 to $200/hr. Pay is set by Mercor and your exact offer depends on your experience and the scope of the work.
Is the Biotech Investment Analyst, Drug Asset & Company Assessment role remote, and can I work from home?
Yes. Mercor lists this Biotech Investment Analyst, Drug Asset & Company Assessment position as fully remote, so you can work from home or anywhere with a reliable computer and internet connection.
Is Biotech Investment Analyst, Drug Asset & Company Assessment full time or part time?
Mercor lists this as a part-time remote role. Full details are in the role description above.
Which countries can apply for Biotech Investment Analyst, Drug Asset & Company Assessment?
Mercor lists eligibility for US-based or deep US-market experience. Check the Mercor listing for current requirements before applying.
Do I need experience to apply for Biotech Investment Analyst, Drug Asset & Company Assessment?
The requirements are listed in the role description above. Mercor screens applicants through its own process, and relevant skills or credentials strengthen your application.
How do I apply for the Biotech Investment Analyst, Drug Asset & Company Assessment role, and is it legit?
Use the apply button on this page to go straight to the official Mercor listing. Mercor is a real hiring marketplace and applying is free. No legitimate employer charges you to apply.
Stay Updated on Roles Like This
Subscribe to receive fresh openings aligned with AI Training & Evaluation and AI training roles across Mercor and JobHub by NeonLabs